On behalf of the Boonton/Boonton Township herd of wandering whitetails (the “Rampaging Ruminants”), I’d like to personally thank you for your donation of land and foodstuffs during this past season.
After a winter of the typical boring forest fare, my companions and I found your yard and its carefully cultivated hors d’oeuvres to be particularly engaging. [...]
Archive for September, 2008
From the CEO: Deer Mr. Woodruff…
Posted in Fun, tagged deer, Venison on September 26, 2008 | Leave a Comment »
Pharma News 9_26
Posted in Allergan, Biotech, Boehringer Ingelheim, Genentech, Healthcare, Lilly, Medical Devices, Medicine, Merck, News, Oncology, Pharma, Pharma News, Pharmaceutical, Roche, Schering, Takeda, Wyeth, tagged AER, Cancer, Genentech, medicis, OSI Pharmaceuticals, paxil, Pfizer, Schering Plough, tarceva, Wyeth on September 26, 2008 | Leave a Comment »
The Sales Force Shuffle, from Pharmaceutical Executive – The last week the pharma atmosphere was abuzz with news about sales force cuts, outsourcing, and overhauls. First, Schering-Plough announced that it had eliminated the 1,000 sales positions it said it would trim in April. This is being done as part of a new sales model called—internally—a [...]
After Hours 9_26
Posted in After Hours, Fun, Video, tagged air traffic, tiger woods on September 26, 2008 | Leave a Comment »
I want this desktop doomsday device.
Yes, even wine can be politicized!
There’s no place like a new home office!
A much cooler version of something we’ve shown before – a worldwide map showing the traffic patterns of airplanes over the span of a day. Very cool!
Even if you’re not into golf, this amazing [...]
Training Tidbits 9_19
Posted in Training, eLearning, tagged DigitalMedia, Distance Learning, learning, Training technology on September 19, 2008 | 1 Comment »
FREE Webinar next week: Learn what’s shaking up the learning industry and what’s causing it to reevaluate its strategies when you join Training magazine for a live, interactive Webinar, as Training Technology in Action Conference & Awards host Bryan Chapman discusses the five major trends driving changes within the industry. Tuesday, Sept. 30 – all [...]
Pharma News 9_19
Posted in Biotech, FDA, GSK, Glaxosmithkline, J&J, Johnson and Johnson, Marketing, Medicine, Merck, Obesity, Pharma, Pharma News, Pharmaceutical, Roche, Schering, tagged Food and Drug Administration, Glaxosmithkline, Johnson & Johnson, Schering Plough, UCB on September 19, 2008 | Leave a Comment »
Huge cuts at Schering-Plough: 1,000 sales jobs going away – As part of a reorganization already under way, the drugmaker is eliminating 1,000 sales jobs – or 20 percent of its sales force – by October. Many of the 4,000 or so surviving reps, meanwhile, will be shifted to pitch different types of docs or [...]
After Hours 9_19
Posted in After Hours, Fun, tagged Amateur astronomy, Astronomy, Globular cluster on September 19, 2008 | Leave a Comment »
A couple of very cool astronomy pictures – the shadow of an eclipse on earth (from orbit); and, an image of my favorite deep space object, a globular cluster (way back when, I owned a telescope and was a backyard amateur astronomer – one day I aspire to live somewhere with dark skies and renew [...]
All Aboard!
Posted in Meetings, Training, tagged Human resources, Mid-NJ ASTD, on-boarding, Scott Mason on September 19, 2008 | Leave a Comment »
Attended a local ASTD (Mid-NJ chapter) last night, which was on the topic of On-Boarding. Scott Mason of BlessingWhite gave a very interesting talk, which was peppered with all kinds of audience involvement – this was clearly a hot topic for folks in the audience.
Having worked deeply with one client on a revamp of the [...]
Pharma News 9_12
Posted in Allergan, AstraZeneca, BMS, Bayer, Biotech, Celgene, Cephalon, Daiichi Sankyo, FDA, GSK, Genentech, Glaxosmithkline, J&J, Johnson and Johnson, Lilly, News, Novartis, Oncology, Pfizer, Pharma, Pharma News, Pharmaceutical, Roche, Sanofi-Aventis, Takeda, tagged afinitor, Alpharma, Amgen, Biogen-Idec, botox, Carl Icahn, everolimus, imclone, Januvia, king, medicis, medivation, Merck, onglyza, provigil; shire, Rituxan, Tysabri, U.S. Food and Drug Administration, UCB Pharma, valeant, vyvanse, Zimmer on September 12, 2008 | 1 Comment »
King begins hostile takeover proceedings with Alpharma – Brain Markison, King’s ceo, is disappointed that Dean Mitchell, Alpharma’s ceo, hasn’t responded to his initial offer $1.4 billion offer, which amounted to $33 a share. So Markison raised the bid to $37, or $1.6 billion, and is going directly to shareholders…more
J&J’s Christine Poon to retire.
ImClone to [...]








